Greenwich LifeSciences expands clinical trial sites to Spain with GEICAM partnership for their Phase III trial evaluating GLSI-100 to prevent breast cancer recurrences.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing
Greenwich LifeSciences, Inc. (GLSI) Stock Price, News, Quote & History - Yahoo Finance
